1. Home
  2. HCAI vs NOTV Comparison

HCAI vs NOTV Comparison

Compare HCAI & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$0.22

Market Cap

11.7M

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.26

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAI
NOTV
Founded
2004
1974
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
12.4M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
HCAI
NOTV
Price
$0.22
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
496.2K
482.5K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
49.64
EPS
N/A
N/A
Revenue
N/A
$547,656,000.00
Revenue This Year
N/A
$5.28
Revenue Next Year
N/A
$5.42
P/E Ratio
$63.07
N/A
Revenue Growth
N/A
511.19
52 Week Low
$0.20
$0.25
52 Week High
$10.97
$4.29

Technical Indicators

Market Signals
Indicator
HCAI
NOTV
Relative Strength Index (RSI) 35.74 22.01
Support Level $0.21 $0.28
Resistance Level $0.24 $0.33
Average True Range (ATR) 0.03 0.05
MACD -0.00 -0.01
Stochastic Oscillator 16.20 0.08

Price Performance

Historical Comparison
HCAI
NOTV

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: